328 related articles for article (PubMed ID: 22988987)
21. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.
Li P; Harris D; Liu Z; Liu J; Keating M; Estrov Z
PLoS One; 2010 Jul; 5(7):e11859. PubMed ID: 20686606
[TBL] [Abstract][Full Text] [Related]
22. Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo.
Liu Z; Liu J; Zhang T; Shi M; Chen X; Chen Y; Yu J
Pharmacol Res; 2020 Jan; 151():104512. PubMed ID: 31726100
[TBL] [Abstract][Full Text] [Related]
23. Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.
Dave H; Anver MR; Butcher DO; Brown P; Khan J; Wayne AS; Baskar S; Rader C
PLoS One; 2012; 7(12):e52655. PubMed ID: 23285131
[TBL] [Abstract][Full Text] [Related]
24. ROR1: an orphan becomes apparent.
Kipps TJ
Blood; 2022 Oct; 140(14):1583-1591. PubMed ID: 35580162
[TBL] [Abstract][Full Text] [Related]
25. Detection of orphan receptor tyrosine kinase (ROR-1) expression in Egyptian pediatric acute lymphoblastic leukemia.
Shaheen I; Ibrahim N
Fetal Pediatr Pathol; 2012 Jun; 31(3):113-9. PubMed ID: 22369092
[TBL] [Abstract][Full Text] [Related]
26. ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway.
Mao Y; Xu L; Wang J; Zhang L; Hou N; Xu J; Wang L; Yang S; Chen Y; Xiong L; Zhu J; Fan W; Xu J
Biofactors; 2019 May; 45(3):416-426. PubMed ID: 30801854
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.
Saleh RR; Antrás JF; Peinado P; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
Cancer Treat Rev; 2019 Jul; 77():11-19. PubMed ID: 31174180
[TBL] [Abstract][Full Text] [Related]
28. The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle.
Kamizaki K; Doi R; Hayashi M; Saji T; Kanagawa M; Toda T; Fukada SI; Ho HH; Greenberg ME; Endo M; Minami Y
J Biol Chem; 2017 Sep; 292(38):15939-15951. PubMed ID: 28790171
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Daneshmanesh AH; Mozaffari F; Moshfegh A; Hansson L; Razavi SM; Sharifian RA; Rabbani H; Österborg A; Mellstedt H; Shokri F
PLoS One; 2015; 10(11):e0142310. PubMed ID: 26562161
[TBL] [Abstract][Full Text] [Related]
30. Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.
Qi X; Okinaka Y; Nishita M; Minami Y
Genes Cells; 2016 Apr; 21(4):325-34. PubMed ID: 26840931
[TBL] [Abstract][Full Text] [Related]
31. Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.
Choi MY; Widhopf GF; Ghia EM; Kidwell RL; Hasan MK; Yu J; Rassenti LZ; Chen L; Chen Y; Pittman E; Pu M; Messer K; Prussak CE; Castro JE; Jamieson C; Kipps TJ
Cell Stem Cell; 2018 Jun; 22(6):951-959.e3. PubMed ID: 29859176
[TBL] [Abstract][Full Text] [Related]
32. Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism.
Hasan MK; Ghia EM; Rassenti LZ; Widhopf GF; Kipps TJ
Leukemia; 2021 Jun; 35(6):1621-1630. PubMed ID: 33097837
[TBL] [Abstract][Full Text] [Related]
33. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
Shabani M; Naseri J; Shokri F
Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
[TBL] [Abstract][Full Text] [Related]
34. Expression of ROR1 in patients with renal cancer--a potential diagnostic marker.
Rabbani H; Ostadkarampour M; Danesh Manesh AH; Basiri A; Jeddi-Tehrani M; Forouzesh F
Iran Biomed J; 2010 Jul; 14(3):77-82. PubMed ID: 21079657
[TBL] [Abstract][Full Text] [Related]
35. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
Parker BA; Shatsky RA; Schwab RB; Wallace AM; ; Wolf DM; Hirst GL; Brown-Swigart L; Esserman LJ; van 't Veer LJ; Ghia EM; Yau C; Kipps TJ
Breast Cancer Res Treat; 2023 Jun; 199(2):281-291. PubMed ID: 37029329
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferative and Apoptotic Effects of Novel Anti-ROR1 Single-Chain Antibodies in Hematological Malignancies.
Aghebati-Maleki L; Younesi V; Baradaran B; Abdolalizadeh J; Motallebnezhad M; Nickho H; Shanehbandi D; Majidi J; Yousefi M
SLAS Discov; 2017 Apr; 22(4):408-417. PubMed ID: 28328317
[TBL] [Abstract][Full Text] [Related]
37. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
[TBL] [Abstract][Full Text] [Related]
38. Targeting malignant B cells with an immunotoxin against ROR1.
Baskar S; Wiestner A; Wilson WH; Pastan I; Rader C
MAbs; 2012; 4(3):349-61. PubMed ID: 22531447
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
Daneshmanesh AH; Hojjat-Farsangi M; Khan AS; Jeddi-Tehrani M; Akhondi MM; Bayat AA; Ghods R; Mahmoudi AR; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H
Leukemia; 2012 Jun; 26(6):1348-55. PubMed ID: 22289919
[TBL] [Abstract][Full Text] [Related]
40. Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia.
Shabani M; Asgarian-Omran H; Vossough P; Sharifian RA; Faranoush M; Ghragozlou S; Khoshnoodi J; Roohi A; Jeddi-Tehrani M; Mellstedt H; Rabbani H; Shokri F
Leuk Lymphoma; 2008 Jul; 49(7):1360-7. PubMed ID: 18604725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
